A Study of BGB-11417 in Participants With Myeloid Malignancies
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study will determine the safety, tolerability, recommended Phase 2 dose (RP2D) and preliminary efficacy of BGB-11417 as monotherapy and in combination with azacitidine in participants with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)or MDS/myeloproliferative neoplasm (MPN) .
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzona diagnoza białaczki szpikowej (nie białaczki promyelocytowej), zespołu mielodysplastycznego lub zespołu mielodysplastyczno-mieloproliferacyjnego
- •Ogólny stan zdrowia pozwalający na przyjęcie zabiegu (skala 0-2)
- •Prawidłowe funkcjonowanie nerek (wskaźnik przesączania ≥50 mL/min, lub 30-49 dla pacjentów w słabszym stanie)
- •Prawidłowe funkcjonowanie wątroby
- •Oczekiwana długość życia ponad 12 tygodni
- •Zdolność do uczestniczenia w badaniu
✗ Disqualifies
- •Diagnoza białaczki promyelocytowej
- •Poprzednia terapia inhibitorami BCL-2
- •Zaangażowanie układu nerwowego przez białaczkę
- •Pierwotna choroba mieloproliferacyjna taka jak mielofibrozja, nadpłytkowość samorództwu lub wieloczerwienkowatość
- •Historia wcześniejszych nowotworów (z pewnymi wyjątkami dla chorób przemienionych w białaczkę lub leczonych 2+ lata temu)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 13, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (46)
City of Hope National Medical Center
Duarte, United States
Tampa General Hospital
Tampa, United States
Upmc Hillman Cancer Center(Univ of Pittsburgh)
Pittsburgh, United States
Md Anderson Cancer Center
Houston, United States
Medical College of Wisconsin
Milwaukee, United States
Concord Repatriation General Hospital
Concord, Australia
St George Hospital
Kogarah, Australia
Orange Health Hospital
Orange, Australia
Gold Coast University Hospital
Southport, Australia
Monash Health
Clayton, Australia
St Vincents Hospital Melbourne
Fitzroy, Australia
Austin Health
Heidelberg, Australia
The Alfred Hospital
Melbourne, Australia
Fiona Stanley Hospital
Murdoch, Australia
Linear Clinical Research
Nedlands, Australia
One Clinical Research
Nedlands, Australia
Peking University Peoples Hospital
Beijing, China
The First Hospital of Lanzhou University
Lanzhou, China
Guangdong Provincial Peoples Hospital
Guangzhou, China
Nanfang Hospital, Southern Medical University
Guangzhou, China
The Second Peoples Hospital of Shenzhen
Shenzhen, China
Henan Cancer Hospital
Zhengzhou, China
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
The First Affiliated Hospital of Soochow University
Suzhou, China
The First Affiliated Hospital of Nanchang University Branch Donghu
Nanchang, China
West China Hospital, Sichuan University
Chengdu, China
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Hopital Claude Huriez Chu Lille
Lille, France
Hopital Larchet
Nice, France
Hopital Saint Louis
Paris, France
Universitaetsklinikum Leipzig Aor
Leipzig, Germany
Universitaetsklinikum Ulm
Ulm, Germany
Policlinico Sorsola Malpighi, Aou Di Bologna
Bologna, Italy
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst
Meldola, Italy
Niguarda Cancer Center Division of Hematology
Milan, Italy
North Shore Hospital
Auckland, New Zealand
Wellington Regional Hospital (Ccdhb)
Wellington, New Zealand
Samsung Medical Center
GangnamGu, South Korea
Severance Hospital Yonsei University Health System
SeodaemunGu, South Korea
Hospital de La Santa Creu I Sant Pau
Barcelona, Spain
Hospital Universitario de Salamanca
Salamanca, Spain
Hospital Universitario Virgen Del Rocio
Seville, Spain
Hospital Universitari I Politecnic La Fe
Valencia, Spain
Edinburgh Cancer Centre
Edinburgh, United Kingdom
The Christie Hospital
Greater Manchester, United Kingdom
Trial contact
Study Director
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.